1407 related articles for article (PubMed ID: 28721811)
1. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
Maiese K
Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
[TBL] [Abstract][Full Text] [Related]
2. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
Maiese K
Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
[TBL] [Abstract][Full Text] [Related]
3. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
Maiese K
Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
Maiese K
Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
[TBL] [Abstract][Full Text] [Related]
5. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
Maiese K
Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
[TBL] [Abstract][Full Text] [Related]
6. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
Maiese K
Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways.
Maiese K
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356626
[TBL] [Abstract][Full Text] [Related]
8. Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm.
Maiese K
Front Biosci (Landmark Ed); 2021 Sep; 26(9):614-627. PubMed ID: 34590471
[No Abstract] [Full Text] [Related]
9. Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.
Chong ZZ; Shang YC; Wang S; Maiese K
Prog Neurobiol; 2012 Nov; 99(2):128-48. PubMed ID: 22980037
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.
Maiese K
Int Rev Neurobiol; 2020; 155():1-35. PubMed ID: 32854851
[TBL] [Abstract][Full Text] [Related]
11. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
Maiese K
Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
[TBL] [Abstract][Full Text] [Related]
12. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
Maiese K
Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy.
Lipton JO; Boyle LM; Yuan ED; Hochstrasser KJ; Chifamba FF; Nathan A; Tsai PT; Davis F; Sahin M
Cell Rep; 2017 Jul; 20(4):868-880. PubMed ID: 28746872
[TBL] [Abstract][Full Text] [Related]
14. Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.
Bellanti F; Iannelli G; Blonda M; Tamborra R; Villani R; Romano A; Calcagnini S; Mazzoccoli G; Vinciguerra M; Gaetani S; Giudetti AM; Vendemiale G; Cassano T; Serviddio G
J Alzheimers Dis; 2017; 59(2):615-631. PubMed ID: 28671110
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
Maiese K
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
[No Abstract] [Full Text] [Related]
16. Systems Level Understanding of Circadian Integration with Cell Physiology.
Morris AR; Stanton DL; Roman D; Liu AC
J Mol Biol; 2020 May; 432(12):3547-3564. PubMed ID: 32061938
[TBL] [Abstract][Full Text] [Related]
17. Taking aim at Alzheimer's disease through the mammalian target of rapamycin.
Maiese K
Ann Med; 2014 Dec; 46(8):587-96. PubMed ID: 25105207
[TBL] [Abstract][Full Text] [Related]
18. Circadian Rhythms in Diet-Induced Obesity.
Engin A
Adv Exp Med Biol; 2017; 960():19-52. PubMed ID: 28585194
[TBL] [Abstract][Full Text] [Related]
19. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Maiese K
Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.
Maiese K
Curr Neurovasc Res; 2016; 13(4):329-340. PubMed ID: 27488211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
